3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
16
Carcinoma, Hepatocellular
11
Stomach Neoplasms
6
Neoplasms
5
Colorectal Neoplasms
3
Triple Negative Breast Neoplasms
2
Small Cell Lung Carcinoma
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Myositis
2
Lung Neoplasms
2
Cholangiocarcinoma
2
Vascular Complications
1
Sjogren's Syndrome
1
Scleroderma, Systemic
1
Sarcopenia
1
Recurrence
1
Rectal Neoplasms
1
Plaque, Atherosclerotic
1
Pathologic Complete Response
1
Oropharyngeal Neoplasms
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Mouth Neoplasms
1
Metastatic Colorectal Adenocarcinoma
1
Melanoma
1
Lupus Erythematosus, Systemic
1
Lung Diseases, Interstitial
1
Liver Neoplasms
1
Influenza, Human
1
Immune-Related Adverse Events
1
Interventions
Data Collection
3
Blood Specimen Collection
2
human papillomavirus vaccine, L1 type 16, 18
1
apremilast
1
Watchful Waiting
1
Telemedicine
1
Surveys and Questionnaires
1
Standard of Care
1
Practice Guidelines as Topic
1
Phlebotomy
1
Mycophenolic Acid
1
Methods
1
Mastectomy, Segmental
1
Mammaplasty
1
Interviews as Topic
1
Immunotherapy
1
Immune Checkpoint Inhibitors
1
Educational Status
1
Early Intervention, Educational
1
Dietary Fiber
1
CT-P13
1
Azathioprine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Autoimmune Diseases
×
Immune Checkpoint Inhibitors
×
Clear all
NCT03492242
2019-09-26
CHIMeRA
Groupe Hospitalier Pitie-Salpetriere
Completed
1,000 enrolled